Vivos Therapeutics, Inc. (VVOS) SEC Filings — 2024

Filings

• Vivos Therapeutics Reports Material Agreement and Equity Sales — 8-K · Dec 23, 2024
• Vivos Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Nov 27, 2024
• Vivos Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Vivos Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Vivos Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
• Vivos Therapeutics Files Proxy Materials — DEFA14A · Nov 6, 2024
• Vivos Therapeutics Files Definitive Proxy Statement — DEF 14A · Oct 7, 2024
• Vivos Therapeutics, Inc. SC 13G Filing — SC 13G · Sep 24, 2024
• Vivos Therapeutics Enters Securities Purchase Agreement — 8-K · Sep 20, 2024
• Vivos Therapeutics Files 8-K — 8-K · Sep 18, 2024
• Vivos Therapeutics Reports on Shareholder Nominations — 8-K · Sep 17, 2024
• Vivos Therapeutics Appoints New Director, Discloses Officer Compensation — 8-K · Sep 12, 2024
• Vivos Therapeutics Files 8-K on Financials — 8-K · Aug 15, 2024
• Vivos Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
• Vivos Therapeutics Files 10-K/A Amendment — 10-K/A · Jul 30, 2024
• Vivos Therapeutics Files 8-K Report — 8-K · Jul 10, 2024
• Vivos Therapeutics Closes $10M Public Offering — 8-K · Jun 25, 2024
• Vivos Therapeutics Raises $1.5M in Stock Sale — 8-K · Jun 14, 2024
• Vivos Therapeutics Faces Nasdaq Delisting Concerns — 8-K · May 17, 2024
• Vivos Therapeutics Files 8-K on Financials — 8-K · May 15, 2024
• Vivos Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
• Vivos Therapeutics Sells Subsidiary Vivos Life Sciences — 8-K · May 6, 2024
• Vivos Therapeutics, Inc. Files Amendment No. 1 to S-1 Registration Statement — S-1/A · Apr 22, 2024
• Vivos Therapeutics, Inc. Files S-1 Registration Statement — S-1 · Apr 9, 2024
• Vivos Therapeutics Files 8-K on Financials — 8-K · Mar 29, 2024
• Vivos Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
• Vivos Therapeutics Reports Material Agreement & Unregistered Equity Sales — 8-K · Feb 15, 2024
• Vivos Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
• Vivos Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024